🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Dr. Alejandro Lemor on being selected as a 2024 “30 in Their 30s” honoree by the SCAI Read on to learn how his professional excellence in interventional cardiology is recognized by SCAI: umc.edu/news/News_Arti…

Be careful excluding the benefits of MCS in women after #DangerShock. Yes there are concern about vascular access but women much less likely to get life saving therapies due to bias. Lina Ya’Qoub MD and Alejandro Lemor MD, MS already showed this to us. jacc.org/doi/10.1016/j.…

Wonderful job Kartik Gupta Alejandro Lemor MD, MS , Ahmad, Patrick! Gillian Grafton Jennifer Cowger Pedro Villablanca MD, MSc, FACC, FSCAI William W. O'Neill Use of RV-MCS in all-comers. CVP & lactate predict outcomes in RV failure! onlinelibrary.wiley.com/doi/10.1002/cc…

Dr. Alejandro Lemor has been named a top early-career interventional cardiologist by being selected as one of “30 in Their 30s” honorees by the Society for Cardiovascular Angiography & Interventions. Congrats Alejandro Lemor MD, MS! ummcmedicinenews.org/2024/04/08/764…

Our analysis of patients in Protect III study who revived Impella assisted high risk PCI * N = 1237 from 46 centers * Vast majority (82.5%) of pts had complex CAD, poor hemodynamics AND comorbidities * most patients had 2 or more risk factors even within each domain * angio,

1/2 When MCS? “Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice”👉: ajconline.org/article/S0002-……

Celebrating our second class of SCAI's 30 in Their 30s recipients, an annual award that recognizes the accomplishments of early-career interventional cardiologists who have the qualities required to be one of the field's future leaders. #SCAI2024

Congratulations to a very special group of leaders, many of whom I am privileged to call friends! Ak Michael Megaly Alejandro Lemor MD, MS Asaad Nakhle, MD Ankur Gupta MD PhD Saraschandra Vallabhajosyula, MD MSc Kashish Goel Harsh Golwala Jimmy Kerrigan Sandeep M Patel, M.D. Megha Prasad MD MS Pooja Swamy, MD, FACC, FSCAI Sahil Khera

Our analysis of patients with chronic kidney disease (first report of dialysis pts) who received Impella assisted HRPCI in Protect III CircInterventions #CirculationIntv #MedTwitter #CardioTwitter 💥Lower eGFR had more severely calcified CAD, greater atherectomy usage but no increased

Case submission is open for SCAI Shock! Best saves, worst complications, interesting hemodynamics we want it all! SCAI @scaielm Allison Dupont, MD Sandeep Nathan, MD, MSc Jason N. Katz Robert Roswell Alex Truesdell Perwaiz Meraj

Check out the #SCAISHOCK 2024 preliminary program for a first look at some of the sessions you can attend during the conference this October 17-19 ➡️ scai.confex.com/scai/shock24/m… 📌Register now to join us in Washington, DC: scai.org/2024-scai-shoc… #CardiogenicShock #Shock

Very important work on RVD in NCSI led by Sarah Gorgis, MD Kartik Gupta Alejandro Lemor MD, MS. RVD (defined as RA > 12, PAPI <1) was present in about ~30% of AMI-CS pts. Pts w RVD were sicker, had higher SCAI shock stage, lactate & worse mortality. Journal of Cardiac Failure sciencedirect.com/science/articl…

Have you ever wondered if LOPP during HR-PCI meant anything? Interesting 1/2 of HR-PCI pts supported w/ Impella experienced LOPP. It was not benign! LOPP was associated w/ increased rates of MACCE. More to come in the Protect IV trial. Gregg W. Stone MD Duane Pinto MD MPH Dr. Jeffrey W. Moses

More “why-when MCS” for high-risk PCI: “Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella”👉: 🔗 onlinejcf.com/article/S1071-……

Discover the foundations of #CardiogenicShock and #MCS with SCAI's newest ebook, “Short-Term Mechanical Circulatory Support for Cardiogenic Shock” 📘➡️ scaipro.scai.org/URL/MCSEbookSe… 📖 Section 1 dives into critical topics, including understanding #CS, the use of right heart

📘#SCAIMCSebook Highlight: Chapter 7—Treatment Escalation Guidelines. Early intervention is critical and knowing when to escalate MCS starts with identifying worsening or undertreated #CardiogenicShock. This chapter explores escalation options, key parameters for deteriorating

Save the date! 🗓️ Join us for the Cardiogenic Shock LATAM Symposium 🫀⚡️in beautiful Cancun! An unmissable event for experts and innovators in the field. Stay tuned for more details! #CShockLATAM TecSalud - Sistema de Salud del Tec de Monterrey Guillermo Torre

Wonderful work led by Imran Aziz Ahmad Jabri MD , FACC, FSCAI & YingXu on flow characteristics of reperfusion sheaths w large bore MCS. No difference b/t sheath sizes (as it relates to flow), better flow w active flow vs passive. Need detected sheaths in the future. sciencedirect.com/science/articl…